Place two packs of CBD seeds beside each other, one labelled 1:1 and the other 20:1, and the two look the same: the same brand packaging, same seed count, seeds that nobody’s eye can tell apart. Run them side by side and they part ways at the very first stage and do not meet again. The reason is one single gene, and the easiest way to see what it does is to track the two packs through each stage both share: the breeding that produced them, the seed, the seedling, the flowering room, the cut, the jar, the lab bench and the border. The lines used as reference points throughout are drawn from the range at https://calmcbdseeds.com, which goes 1:1, 2:1 and 20:1 and a highest line at about 30 to one; the biology is the same regardless of which shop the packs come from.
How Each Pack Was Made
Cannabis decides whether it will make THC or CBD at one position on the genome. The gene there comes in two versions: one builds the enzyme that turns the shared precursor into THCA, the other the enzyme that turns it into CBDA. Each plant holds two copies, one inherited from either parent, and the combination fixes the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies make a CBD-dominant one. One of each gives a balanced plant, since the two forms are codominant and neither silences the other.
The balanced pack was bred by pairing two balanced plants, both carrying one copy of each form. The 20:1 pack was bred by crossing two plants that both hold two CBD copies and no THC copy in either of them. That one difference at the cross determines all that follows downstream, and it is already inside the seed before it is packed.
Stage Two: Inside the Seed
Cross two balanced plants and the seeds fall out by the simplest arithmetic in genetics: a quarter inherit two THC copies, a quarter get two CBD copies, half inherit one of each. In a pack of 10 seeds that means, on average, two or three THC-dominant seeds, around two CBD-dominant seeds, and five true balanced seeds. The pack is sold by its parents, and in the case of half its contents the label fits; for the other half it is a description of something else. Calm CBD Seeds states the expected split on each balanced pack, so the buyer knows before sowing that a share of the plants will depart from the stated ratio.
The 20:1 pack has no such spread. Each seed received a CBD copy from each parent, every plant is going to be CBD-dominant, and the ratio on the foil holds to every one of them, within the small differences in the amount of much total cannabinoid any given plant builds. The trade describe such lines “breed true” for chemotype; the term refers to precisely this absence of variation.
Weeks One to Four
Here the two packs look the same once more, and the resemblance holds longer than most growers assume. Chemotype leaves no trace on a seedling. Leaf, vigour, internode length and the speed of growth are governed by other genes entirely, and the different chemotypes of plant in the balanced pack grow indistinguishably beside one another and from each plant in the 20:1 pack.
One practical distinction at this stage arises from lineage not chemotype. Strains with recent hemp ancestry, which covers some older CBD-dominant lines, are inclined to grow rangier and branch less. A heavily selected 20:1 line behaves like a normal modern hybrid; a early-generation one still carry the field in its shape. Neither tendency tells anything about the ratio in the flower.
Stage Four: The Flowering Room
In flower the two packs begin to offer hints, and the majority of them mislead. Resin density is the first one a grower judges, and it was a reasonable rule: early CBD-dominant strains carried visibly less frost than their THC cousins, an unwanted legacy from hemp. Modern selections have mostly closed that gap, and a less resinous plant from the 20:1 pack can still test precisely where the foil promised. Resin density and chemotype are carried separately.
Smell is an even poorer guide. The terpene profile lives on still different genes, so the THC-dominant plant hiding in the balanced pack can smell indistinguishable to the balanced one next to it, and either can smell indistinguishable to a plant from the 20:1 pack. People who try to sort a balanced pack by nose at week eight are guessing, and that is not any better than not unsorted at all.
Stage Five: The Harvest Window
At this stage the two packs diverge in a way that benefits the grower of the 20:1 pack and the CBD-dominant plants sitting in the balanced pack. CBDA degrades rather slowly than THCA, so a CBD-dominant plant left a week beyond its peak keeps the bulk of its cannabinoid content, whereas a THC-dominant one under the same conditions has already begun shedding THC to CBN. The usual trichome rules still applies; it holds on account of the terpenes, which fade on any plant regardless the chemotype, and a late, over-dried CBD flower smells of very little whatever the test result is.
Stage Six: The Jar
The 20:1 pack goes into one jar. Every plant from it holds roughly the same ratio, and mixing them changes nothing worth notice. The balanced pack should never be handled that way. Pool its 10 plants in a single jar and the result become a ratio that nobody’s foil ever predicted, skewed by which plants yielded biggest, and nothing on a subsequent test can untangle what went in.
The discipline that prevents the trouble is almost tedious: harvest the balanced pack plant by plant, cure each apart, label them, and try them plant at a time before anything is combined. It is the one stage in the whole process where the three chemotypes of plant in the balanced pack can still be kept apart short of a laboratory, and then only because each is still in its own container.
Stage Seven: The Lab Report
Submit a sample from every jar to a laboratory and the two packs at last become readable. For the 20:1 pack the reports arrive back grouped tightly around the stated ratio, differing mostly in total output rather than in proportion. For the balanced pack they come back in three groups: some plants with almost all THC, a few showing nearly all CBD, and the majority sitting near one to one. No part of that result is a failure; it is the bench cross expressed as numbers.
Over-the-counter test kits exist for growers who cannot reach a lab, and the majority of them show whether THC is present rather than how much. That is sufficient to pull the THC-dominant plants out from a balanced pack and insufficient to assign a ratio to the others, and that matches the most frequent need: finding out what of the 10 jars will surprise a guest.
Where the Law Reads the Numbers
The last place where the two packs separate is in law, and it trips growers who thought “CBD” was shorthand for “hemp”. The majority of jurisdictions classify hemp by a THC limit, a fraction of a percent of dry weight, and the exact number differing by country and year to year. A plant from the 20:1 pack making twenty percent CBD at twenty to one at the same time makes around one percent THC, and that is several times above most thresholds. Compliant lines are bred to keep total cannabinoid output low so the THC share stays below the line right up to harvest; CBD flower lines are bred for rich output and let the THC rise with it. A seller that offers only a ratio is selling a flower line; a grower who requires a legal hemp crop should ask for a tested THC figure at maturity and order nothing that cannot show one.
Past the threshold issue, the chemotype alters nothing in the law on the seed as such. In places where owning cannabis seeds is lawful and germinating them is not, the balanced pack and the 20:1 pack fall in the same rule as every other pack. Where the plant is permitted outright, the decision between them is a matter of preference and nothing else’s. None of this page is legal advice, and the law which applies is the one where the seed is going to be sown, rather than the one in the place it was bought.
